ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC61178-5mg |
|
118555-82-1 |
Phaseoloidin
|
0 | — | |
GC61177-100mg |
|
425629-94-3 |
PfDHODH-IN-2
|
0 | — | |
GC61177-50mg |
|
425629-94-3 |
PfDHODH-IN-2
|
0 | — | |
GC61177-25mg |
|
425629-94-3 |
PfDHODH-IN-2
|
0 | — | |
GC61177-10mg |
|
425629-94-3 |
PfDHODH-IN-2
|
0 | — | |
GC61177-5mg |
|
425629-94-3 |
PfDHODH-IN-2
|
0 | — | |
GC61177-10mM (in 1mL DMSO) |
|
425629-94-3 |
PfDHODH-IN-2
|
0 | — | |
GC61176-100mg |
|
1817628-40-2 |
PF-06426779
|
0 | — | |
GC61176-50mg |
|
1817628-40-2 |
PF-06426779
|
0 | — | |
GC61176-25mg |
|
1817628-40-2 |
PF-06426779
|
0 | — | |
GC61176-10mg |
|
1817628-40-2 |
PF-06426779
|
0 | — | |
GC61176-5mg |
|
1817628-40-2 |
PF-06426779
|
0 | — | |
GC61176-10mM (in 1mL DMSO) |
|
1817628-40-2 |
PF-06426779
|
0 | — | |
GC61175-5mg |
|
— |
PF-06305591 dihydrate
|
0 | — | |
GC61174-5mg |
|
1235397-05-3 |
PF-04856264
|
0 | — | |
GC61173-50mg |
|
380610-27-5 |
Pertuzumab
|
0 | — | |
GC61173-25mg |
|
380610-27-5 |
Pertuzumab
|
0 | — | |
GC61173-5mg |
|
380610-27-5 |
Pertuzumab
|
0 | — | |
GC61173-1mg |
|
380610-27-5 |
Pertuzumab
|
0 | — | |
GC61172-5mg |
|
28590-40-1 |
Persicogenin
|
0 | — | |